Navigation Links
Sandia Biotech, Inc. and Sigma-Aldrich Enter into Global Distribution and Marketing Agreement
Date:9/26/2013

Albuquerque, NM (PRWEB) September 26, 2013

Sandia Biotech, Inc., an Albuquerque, NM based, privately held biotech development and manufacturing company has signed a co-exclusive, global distribution agreement with Sigma-Aldrich for its Split Fluorescent Protein (sFP) product line, which is based on technology licensed from Los Alamos National Laboratory (LANL). Sandia Biotech will continue to manufacture its novel Split Green Fluorescent Protein (sGFP) product line in Albuquerque, NM.

Sandia Biotech’s sFP technology, which includes several easy-to-use kits that are available in green, yellow and cyan variations, is utilized in protein and peptide analysis by the pharmaceutical drug development and industrial biotech communities. Proteins and peptides can be analyzed with standard instrumentation, and as such, the purchase of new equipment will typically not be necessary. Drug developers will find the advantages of this technology over those currently in use to include simplicity and increased specificity with a concomitant reduction in false positives, development costs, analysis time and reagent costs. Furthermore, this technology is capable of providing information on protein folding and aggregation that can also significantly reduce development costs.

Sandia Biotech’s products are utilized by a broad range of institutional and commercial entities worldwide that are producing or developing peptide and protein technologies. It is anticipated that this sFP technology will become the preferred tool for protein and peptide analysis, replacing many of those methods currently used in the immunoassay market.

Since June of 2009, Sandia Biotech has exclusively sold this technology to institutions and research laboratories world-wide through its website (http://www.sandiabio.com). In 2012, it introduced its products to major drug developers and pharmaceutical commercial entities.

Says company President, Tony Pino: "We realized from the beginning that the key to making a significant impact in the market place with our novel product line would be to find a major distributor with the capacity to market on a global basis. We are ecstatic that we are able to team up with one of the largest distributors of research biochemicals and kits in the world. Sigma-Aldrich is impressed with the international attention our product line has generated and our sales so far by solely being published in scientific literature, and making our products available via our website."

These innovative products fit well into the existing offering of products for protein and peptide analysis at Sigma-Aldrich. Customers around the globe will benefit from the combined offer. For more information of the combined products in protein and peptide analysis, visit http://www.sigmaaldrich.com/life-science/biochemicals/biochemical-products.html?TablePage=113886902.

About Sandia Biotech, Inc:    

Sandia Biotech specializes in developing and manufacturing protein and peptide analysis tools for the medical, drug development and industrial biotech communities. Its focus is to expand, manufacture and market a Split Green Fluorescent Protein (sGFP) technology licensed from Los Alamos National Laboratory (LANL) in order to gain universal acceptance as a standard detecting and tracking tool of choice for protein and peptide analysis in research institutions, hospitals and industry world-wide. For more information please visit http://www.sandiabio.com.

About Sigma-Aldrich:

Sigma-Aldrich is a leading Life Science and High Technology company whose biochemical, organic chemical products, kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical, diagnostics and high technology manufacturing. Sigma-Aldrich customers include more than 1.3 million scientists and technologists in life science companies, university and government institutions, hospitals and industry. The Company operates in 38 countries and has nearly 9,000 employees whose objective is to provide excellent service worldwide. Sigma-Aldrich is committed to accelerating customer success through innovation and leadership in Life Science and High Technology. For more information about Sigma-Aldrich, please visit its website at http://www.sigma-aldrich.com.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11159339.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Voltage increases up to 25 percent observed in closely packed nanowires at Sandia Labs
2. TNI BioTech, Inc. Announces Death of Senior Vice President and Chief Medical Officer, Dr. Ronald Herberman
3. TNI BioTech, Inc. Appoints Industry Veteran, Dr. Joseph Fortunak, as a Strategic Consultant
4. SHAREHOLDER ALERT: Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of PROLOR Biotech, Inc. in Connection with the Sale of the Company to OPKO Health, Inc.
5. Law Office of Brodsky & Smith, LLC Announces Investigation of PROLOR Biotech, Inc.
6. Preclinical Stage Partnering Terms and Agreements in Pharma and Biotech, 2013 Edition
7. Air Products to Feature Medical and Industrial Grade Gas Solutions for Pharma, Biotech, and Life Science Applications at Mid-Atlantic Bio Conference
8. RayBiotech, Inc. Achieves Both GMP- and GLP-Compliance and Announces New Dedicated Services Laboratory
9. RayBiotech, Inc. and the University of Oslo Enter into Antibody Array Services Collaboration
10. RayBiotech, Inc. Announces New Diagnostic Core Facility Partnering Program
11. Marina Biotech, Inc. Joins OTCQX
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/4/2016)... , February 4, 2016 ... a biotechnology acceleration company is pleased to provide the following ... --> Over the last 3 months we have ... securities purchase agreements exceeding $1,000,000. As a result, we have ... Mannin Research Inc. license agreement and expect that development to ...
(Date:2/4/2016)... February 4, 2016 Strasbourg, France ... Inc. --> Strasbourg, France , to ... PharmaVentures is pleased to announce that it acted as ... manufacturing unit in Strasbourg, France , to ... --> --> Transgene (Euronext: TNG), a ...
(Date:2/3/2016)... Ascendis Pharma A/S (Nasdaq: ASND ), ... TransCon technology to address significant unmet medical needs, today ... Leerink Partners Global Healthcare Conference Location: , Waldorf ... 2016 Time:  , 11:55am EST www.ascendispharma.com ... An audio webcast of this event will be posted ...
(Date:2/3/2016)... (PRWEB) , ... February 03, 2016 , ... ... remote Linux and Unix visualization solutions today announced the addition of a powerful ... allows users to see the current state of the remote Linux desktop or ...
Breaking Biology Technology:
(Date:1/11/2016)... CHICAGO , Jan. 11, 2016  higi, ... via nearly 10,000 retail locations, web and mobile, ... than $40 million from existing investors. ... will be devoted to further innovate higi,s health ... app and web portal – including expanding services ...
(Date:1/8/2016)... 8, 2016 NXTD ), a ... ® , a privately held leading direct seller of ... 5000 fastest-growing company announced that on December 31, ... million in Nxt-ID to develop a proprietary new wireless ... ® , a unique smart wallet that serves to ...
(Date:1/7/2016)... Jan. 7, 2016 Various factors have ... products such as biologics and biosimilars. Some of ... healthcare expenditure, growing demand for cost-effective alternatives, growing ... Biosimilars are similar versions of their corresponding patented ... their quality, safety, and efficacy. The global biosimilars ...
Breaking Biology News(10 mins):